$0.779600
0.045.00%
Pre-Market: 5:33 PM EDT
15 minutes delayed
Comments
Loading...
Cue Biopharma
CUENASDAQ
Cue Biopharma (NASDAQ:CUE) Stock, Earnings Estimates, EPS, And Revenue
Cue Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 7
EPS Estimate
$-0.290
Quarterly Revenue Estimate
$1.3M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$7M
Analyze the earnings history of Cue Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma | -$0.29 | -$0.29 | — | — | $1.38M | $1.29M | — | — | 08/07/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.29 | -$0.28 | -$0.25 | 10.71% | $187.00K | $1.21M | $1.72M | 41.90% | 05/09/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.37 | -$0.28 | -$0.28 | 0.00% | $151.00K | $1.71M | $1.82M | 6.49% | 04/08/2024 | Get Alert |
| CUE | Cue Biopharma | -$0.31 | -$0.34 | -$0.24 | 29.41% | $68.00K | $1.13M | $2.10M | 85.84% | 11/03/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.37 | -$0.30 | -$0.29 | 3.33% | $26.00K | $1.21M | $1.38M | 14.21% | 08/09/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.44 | -$0.29 | -$0.29 | 0.00% | $1.00M | $1.95M | $187.00K | -90.41% | 05/09/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.25 | -$0.31 | -$0.37 | -19.35% | $8.25M | $100.00K | $151.00K | 51.00% | 03/21/2023 | Get Alert |
| CUE | Cue Biopharma | -$0.41 | -$0.38 | -$0.31 | 18.42% | $2.40M | $440.00K | $68.00K | -84.55% | 11/14/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.33 | -$0.42 | -$0.37 | 11.90% | $2.74M | — | $26.00K | — | 08/04/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.41 | -$0.43 | -$0.44 | -2.33% | $1.55M | $3.05M | $1.00M | -67.21% | 05/10/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.36 | -$0.38 | -$0.25 | 34.21% | $475.00K | — | $8.25M | — | 03/16/2022 | Get Alert |
| CUE | Cue Biopharma | -$0.34 | -$0.39 | -$0.41 | -5.13% | $704.00K | — | $2.40M | — | 10/27/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.38 | -$0.42 | -$0.33 | 21.43% | $1.07M | $1.06M | $2.74M | 158.40% | 08/17/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.48 | -$0.38 | -$0.41 | -7.89% | $900.00K | — | $1.55M | — | 05/17/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.37 | -$0.35 | -$0.37 | -5.71% | $1.05M | $1.33M | $475.00K | -64.29% | 03/16/2021 | Get Alert |
| CUE | Cue Biopharma | -$0.31 | — | -$0.34 | — | $984.00K | — | $704.00K | — | 11/09/2020 | Get Alert |
| CUE | Cue Biopharma | -$0.46 | — | -$0.38 | — | $1.05M | — | $1.07M | — | 08/10/2020 | Get Alert |
| CUE | Cue Biopharma | -$0.54 | — | -$0.48 | — | $370.00K | — | $900.00K | — | 05/19/2020 | Get Alert |
| CUE | Cue Biopharma | -$0.58 | -$0.40 | -$0.37 | 7.50% | $331.00K | $2.40M | $1.05M | -56.29% | 03/17/2020 | Get Alert |
| CUE | Cue Biopharma | -$0.62 | — | -$0.31 | — | $449.00K | — | $984.00K | — | 11/12/2019 | Get Alert |
| CUE | Cue Biopharma | -$0.36 | — | -$0.46 | — | $172.00K | — | $1.05M | — | 08/08/2019 | Get Alert |
Cue Biopharma (CUE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.25 | $-0.28 | 10.7 % |
| Mar 2024 | 2024-04-08 | $-0.28 | $-0.28 | 0.00 % |
| Sep 2023 | 2023-11-03 | $-0.24 | $-0.34 | 29.4 % |
| Jun 2023 | 2023-08-09 | $-0.29 | $-0.30 | 3.33 % |
Cue Biopharma (CUE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $1.72M | $1.21M | 41.9 % |
| Mar 2024 | 2024-04-08 | $1.82M | $1.71M | 6.49 % |
| Sep 2023 | 2023-11-03 | $2.10M | $1.13M | 85.8 % |
| Jun 2023 | 2023-08-09 | $1.38M | $1.21M | 14.2 % |
FAQ
When is Cue Biopharma (NASDAQ:CUE) reporting earnings?
Cue Biopharma (CUE) is scheduled to report earnings on August 7, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Cue Biopharma (NASDAQ:CUE)?
The Actual EPS was $-0.25, which beat the estimate of $-0.28.
What were Cue Biopharma’s (NASDAQ:CUE) revenues?
The Actual Revenue was $1.7M, which beat the estimate of $1.2M.
Browse earnings estimates, EPS, and revenue on all stocks.